SFDA Approves the Registration of Elrexfio for the Treatment of Adults with Multiple Myeloma
Riyadh: The Saudi Food and Drug Authority (SFDA) has approved the registration of Elrexfio (Elranatamab) for the treatment of adult patients with relapsed or refractory